As Vice President of Finance at Jazz Pharmaceuticals, Alan FCCA plays a pivotal role in steering the financial strategy and operational leadership of the finance function across the US and Canada. With a deep understanding of the pharmaceutical industry, Alan is responsible for overseeing a...
As Vice President of Finance at Jazz Pharmaceuticals, Alan FCCA plays a pivotal role in steering the financial strategy and operational leadership of the finance function across the US and Canada. With a deep understanding of the pharmaceutical industry, Alan is responsible for overseeing a wide array of accounting operations, including procure-to-pay and order-to-cash processes, payroll, stock administration, and travel and expense management. His expertise extends to government price reporting, tax compliance, and financial due diligence, ensuring that Jazz Pharmaceuticals remains compliant with the Sarbanes-Oxley Act and SEC filings.
Alan's strategic vision is complemented by his hands-on approach to M&A integrations and alliance management, where he leverages his strong technical skills in US GAAP and SAP to drive financial performance and operational efficiency. His leadership style fosters a collaborative environment, allowing him to build and engage high-performing teams that are adept at navigating complex financial landscapes. By resolving multifaceted issues with integrity and diligence, Alan has established himself as a trusted advisor within the organization.
Key projects under his stewardship include the optimization of financial processes to enhance reporting accuracy and timeliness, as well as spearheading initiatives that align financial strategy with the company’s growth objectives. Alan’s commitment to excellence and his ability to adapt to the ever-evolving pharmaceutical landscape make him a vital asset to Jazz Pharmaceuticals, ensuring that the finance function not only supports but also drives the company’s strategic goals.
